Literature DB >> 26308288

The synthesis of (Z)-4-oxo-4-(arylamino)but-2-enoic acids derivatives and determination of their inhibition properties against human carbonic anhydrase I and II isoenzymes.

Koray Oktay1, Leyla Polat Köse1, Kıvılcım Şendil2, Mehmet Serdar Gültekin1, İlhami Gülçin1,3, Claudiu T Supuran4,5.   

Abstract

The synthesis of (Z)-4-oxo-4-(arylamino)but-2-enoic acid (4) derivatives containing structural characteristics that can be used for the synthesis of several active molecules, is presented. Some of the butenoic acid derivatives (4a, 4c, 4e, 4i, 4j, 4k) are synthesized following literature procedures and at the end of the reaction. In addition, structures of all synthesized derivatives (4a-4m) were determined by (1)H-NMR, (13)C-NMR and IR spectroscopy. Carbonic anhydrase is a metalloenzyme involved in many crucial physiologic processes as it catalyzes a simple but fundamental reaction, the reversible hydration of carbon dioxide to bicarbonate and protons. Significant results were obtained by evaluating the enzyme inhibitory activities of these derivatives against human carbonic anhydrase hCA I and II isoenzymes (hCA I and II). Butenoic acid derivatives (4a-4m) strongly inhibited hCA I and II with Kis in the low nanomolar range of 1.85 ± 0.58 to 5.04 ± 1.46 nM against hCA I and in the range of 2.01 ± 0.52 to 2.94 ± 1.31 nM against hCA II.

Entities:  

Keywords:  Butenoic acid; carbonic anhydrase; enzyme inhibition; enzyme purification; isoenzymes

Mesh:

Substances:

Year:  2015        PMID: 26308288     DOI: 10.3109/14756366.2015.1071808

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  1 in total

1.  Synthesis and bioactivity of several new hetaryl sulfonamides.

Authors:  Parham Taslimi; Afsun Sujayev; Sevgi Mamedova; Pınar Kalın; İlhami Gulçin; Nastaran Sadeghian; Sukru Beydemir; O Irfan Kufrevioglu; Saleh H Alwasel; Vagif Farzaliyev; Sabir Mamedov
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.